Nitric oxide and poly(ADP-ribose) polymerase in neuronal cell death

Cell Death: The Role of Poly (ADP-ribose) Polymerase

Volumn , Issue , 2000, Pages 7-22

  Zhang, Jie ^a   Snyder, Solomon H ^b  

^a GUILFORD PHARMACEUTICALS INC   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0041550796     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/9781420038897     Document Type: Chapter

References (79)

1. Benveniste, H., Drejer, J., Schousboe, A., and Diemer, N.H., Elevation of the extracellular concentrations of glutamate and aspartate in rat hippocampus during transient cerebral ischemia monitored by intracerebral microdialysis. J. Neurochem., 43: 1369-1374, 1984.
2. Choi, D.W., Koh, J.Y., and Peters, S., Pharmacology of glutamate neurotoxicity in cortical cell culture: attenuation by NMDA antagonists. J. Neurosci., 8: 185-196, 1988.
3. Wolosker, H., Sheth, K.N., Takahashi, M., Mothet, J.P., Brady, R.O., Jr., Ferris, C.D., and Snyder, S.H., Purification of serine racemase: biosynthesis of the neuromodulator D-serine. Proc. Natl. Acad. Sci. U.S.A., 96: 721-725, 1999.
4. Garthwaite, J., Charles, S.L., and Chess-Williams, R., Endothelium-derived relaxing factor release on activation of NMDA receptors suggests role as intercellular messenger in the brain. Nature, 336: 385-388, 1988.
5. Bredt, D.S. and Snyder, S.H., Nitric oxide mediates glutamate-linked enhancement of cGMP levels in the cerebellum. Proc. Natl. Acad. Sci. U.S.A., 86: 9030-9033, 1989.
6. Garthwaite, J., Garthwaite, G., Palmer, R.M., and Moncada, S., NMDA receptor activation induces nitric oxide synthesis from arginine in rat brain slices. Eur. J. Pharmacol., 17: 413-416, 1989.
7. Bredt, D.S. and Snyder, S.H., Isolation of nitric oxide synthetase, a calmodulinrequiring enzyme. Proc. Natl. Acad. Sci. U.S.A., 87: 682-685, 1990.
8. Brenman, J.E., Chao, D.S., Gee, S.H., McGee, A.W., Craven, S.E., Santillano, D.R., Wu, Z., Huang, F., Xia, H., Peters, M.F., Froehner, S.C., and Bredt, D.S., Interaction of nitric oxide synthase with the postsynaptic density protein PSD-95 and alpha1-syntrophin mediated by PDZ domains. Cell, 84: 757-767, 1996.
9. Kornau, H.C., Schenker, L.T., Kennedy, M.B., and Seeburg, P.H., Domain interaction between NMDA receptor subunits and the postsynaptic density protein PSD-95. Science, 269: 1737-1740, 1995.
10. Bredt, D.S., Hwang, P.M., and Snyder, S.H., Localization of nitric oxide synthase indicating a neural role for nitric oxide. Nature, 347: 768-770, 1990.
11. Bredt, D.S., Hwang, P.M., Glatt, C.E., Lowenstein, C., Reed, R.R., and Snyder, S.H., Cloned and expressed nitric oxide synthase structurally resembles cytochrome P-450 reductase. Nature, 351: 714-718, 1991.
12. Xie, Q.W., Cho, H.J., Calaycay, J., Mumford, R.A., Swiderek, K.M., Lee, T.D., Ding, A., Troso, T., and Nathan, C., Cloning and characterization of inducible nitric oxide synthase from mouse macrophages. Science, 256: 225-228, 1992.
13. Lowenstein, C.J., Glatt, C.S., Bredt, D.S., and Snyder, S.H., Cloned and expressed macrophage nitric oxide synthase contrasts with the brain enzyme. Proc. Natl. Acad. Sci. U.S.A., 89: 6711-6715, 1992.
14. Lyons, C.R., Orloff, G.J., and Cunningham, J.M., Molecular cloning and functional expression of an inducible nitric oxide synthase from a murine macrophage cell line. J. Biol. Chem., 267: 6370-6374, 1992.
15. Lamas, S., Marsden, P.A., Li, G.K., Tempst, P., and Michel, T., Endothelial nitric oxide synthase: molecular cloning and characterization of a distinct constitutive enzyme isoform. Proc. Natl. Acad. Sci. U.S.A., 89: 6348-6352, 1992.
16. Sessa, W.C., Harrison, J.K., Barber, C.M., Zeng, D., Durieux, M.E., D’Angelo, D.D., Lynch, K.R., and Peach, M.J., Molecular cloning and expression of a cDNA encoding endothelial cell nitric oxide synthase. J. Biol. Chem., 267: 15274-1526, 1992.
17. Janssens, S.P., Simouchi, A., Quertermous, T., Bloch, D.B., and Bloch, K.D., Cloning and expression of a cDNA encoding human endothelium-derived relating factor/nitric oxide synthase. J. Biol. Chem., 267: 14519-14522, 1992.
18. Dawson, T.M., Bredt, D.S., Fotuhi, M., Hwang, P.M., and Snyder, S.H., Nitric oxide synthase and neuronal NADPH diaphorase are identical in brain and peripheral tissues. Proc. Natl. Acad. Sci. U.S.A., 88: 7797-7801, 1991.
19. Dawson, V.L., Dawson, T.M., London, E.D., Bredt, D.S., and Snyder, S.H., Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures. Proc. Natl. Acad. Sci. U.S.A., 88: 6368-6371, 1991.
20. Dawson, V.L., Kizushi, V.M., Huang, P.L., Snyder, S.H., and Dawson, T.M., Resistance to neurotoxicity in cortical cultures from neuronal nitric oxide synthase-deficient mice. J. Neurosci., 16: 2479-2487, 1996.
21. Dawson, V.L. and Dawson, T.M., Nitric oxide in neurodegeneration. Prog. Brain Res., 118: 215-229, 1998.
22. Huang, Z., Huang, P.L., Panahian, N., Dalkara, T., Fishman, M.C., and Moskowitz, M.A., Effects of cerebral ischemia in mice deficient in neuronal nitric oxide synthase. Science, 265: 1883-1885, 1994.
23. Brenman, J.E., Xia, H., Chao, D.S., Black, S.M., and Bredt, D.S., Regulation of neuronal nitric oxide synthase through alternative transcripts. Dev. Neurosci., 19: 224-231, 1997.
24. Eliasson, M.J., Blackshaw, S., Schell, M.J., and Snyder, S.H., Neuronal nitric oxide synthase alternatively spliced forms: prominent functional localizations in the brain. Proc. Natl. Acad. Sci. U.S.A., 94: 3396-3401, 1997.
25. Huang, P.L., Dawson, T.M., Bredt, D.S., Snyder, S.H., and Fishman, M.C., Targeted disruption of the neuronal nitric oxide synthase gene. Cell, 75: 1273-1286, 1993.
26. Eliasson, M.J., Huang, Z., Ferrante, R.J., Sasamata, M., Molliver, M.E., Snyder, S.H., and Moskowitz, M.A., Neuronal nitric oxide synthase activation and peroxynitrite formation in ischemic stroke linked to neural damage. J. Neurosci., 19: 5910-5918, 1999.
27. Lander, H.M., Ogiste, J.S., Pearce, S.F., Levi, R., and Novogrodsky, A., Nitric oxidestimulated guanine nucleotide exchange on p21ras. J. Biol. Chem., 270: 7017-7020, 1995.
28. Jaffrey, S.R., Cohen, N.A., Rouault, T.A., Klausner, R.D., and Snyder, S.H., The ironresponsive element binding protein: a target for synaptic actions of nitric oxide. Proc. Natl. Acad. Sci. U.S.A., 91: 12994-12998, 1994.
29. Brune, B. and Lapetina, E.G., Activation of a cytosolic ADP-ribosyltransferase by nitric oxide-generating agents. J. Biol. Chem., 264: 8455-9458, 1989.
30. Zhang, J. and Snyder, S.H., Purification of a nitric oxide-stimulated ADP-ribosylated protein using biotinylated beta-nicotinamide adenine dinucleotide. Biochemistry, 32: 2228-2233, 1993.
31. Zhang, J. and Snyder, S.H., Nitric oxide stimulates auto-ADP-ribosylation of glyceraldehyde-3-phosphate dehydrogenase. Proc. Natl. Acad. Sci. U.S.A., 89: 9382-9385, 1992.
32. Dimmeler, S., Lottspeich, F., and Brune, B., Nitric oxide causes ADP-ribosylation and inhibition of glyceraldehyde-3-phosphate dehydrogenase. J. Biol. Chem., 267: 16771-16774, 1992.
33. Kots, A.Y.A., Skurat, A.V., Sergienko, E.A., Bulargina, T.V., and Severin, E.S., Nitroprusside stimulates the cysteine-specific mono(ADP-ribosylation) of glyceraldehyde-3-phosphate dehydrogenase from human erythrocytes. FEBS Lett., 300: 9-12, 1992.
34. McDonald, L.J. and Moss, J., Stimulation by nitric oxide of an NAD linkage to glyceraldehyde-3-phosphate dehydrogenase. Proc. Natl. Acad. Sci. U.S.A., 90: 6238-6241, 1993.
35. Minetti, M., Pietraforte, D., Di Stasi, A.M., and Mallozzi, C., Nitric oxide-dependent NAD linkage to glyceraldehyde-3-phosphate dehydrogenase: possible involvement of a cysteine thiol radical intermediate. Biochem. J., 319: 369-375, 1996.
36. Kots, A.Y.A., Sergienko, E.A., Bulargina, T.V., and Severin, E.S., Glyceraldehyde-3-phosphate activates auto-ADP-ribosylation of glyceraldehyde-3-phosphate dehydrogenase. FEBS Lett., 324: 33-36, 1993.
37. Dimmeler, S. and Brune, B., Nitric oxide preferentially stimulates auto-ADP-ribosylation of glyceraldehyde-3-phosphate dehydrogenase compared to alcohol or lactate dehydrogenase. FEBS Lett., 315: 21-24, 1993.
38. Sawa, A., Khan, A.A., Hester, L.D., and Snyder, S.H., Glyceraldehyde-3-phosphate dehydrogenase: nuclear translocation participates in neuronal and nonneuronal cell death. Proc. Natl. Acad. Sci. U.S.A., 94: 11669-11674, 1997.
39. Saunders, P.A., Chen, R.W., and Chuang, D.M., Nuclear translocation of glyceraldehyde-3-phosphate dehydrogenase isoforms during neuronal apoptosis. J. Neurochem., 72: 925-932, 1997.
40. Sirover, M.A., Role of the glycolytic protein, glyceraldehyde-3-phosphate dehydrogenase, in normal cell function and in cell pathology. J. Cell. Biochem., 66: 133-140, 1997.
41. Singh, R. and Green, M.R., Sequence-specific binding of transfer RNA by glyceraldehyde-3-phosphate dehydrogenase. Science, 259: 365-368, 1993.
42. Baxi, M.D. and Vishwanatha, J.K., Uracil DNA-glycosylase/glyceraldehyde-3-phosphate dehydrogenase is an Ap4A binding protein. Biochemistry, 34: 9700-9707, 1995.
43. Tokunaga, K., Nakamura, Y., Sakata, K., Fujimori, K., Ohkubo, M., Sawada, K., and Sakiyama, S., Enhanced expression of a glyceraldehyde-3-phosphate dehydrogenase gene in human lung cancers. Cancer Res., 47: 5616-5619, 1987.
44. Ishitani, R., Sunaga, K., Hirano, A., Saunders, P., Katsube, N., and Chuang, D.M., Evidence that glyceraldehyde-3-phosphate dehydrogenase is involved in age-induced apoptosis in mature cerebellar neurons in culture. J. Neurochem., 66: 928-935, 1996.
45. Shashidharan, P., Chalmers-Redman, R.M., Carlile, G.W., Rodic, V., Gurvich, N., Yuen, T., Tatton, W.G., and Sealfon, S.C., Nuclear translocation of GAPDH-GFP fusion protein during apoptosis. Neuroreport, 10: 1149-1153, 1999.
46. Ishitani, R. and Chuang, D.M., Glyceraldehyde-3-phosphate dehydrogenase antisense oligodeoxynucleotides protect against cytosine arabinonucleoside-induced apoptosis in cultured cerebellar neurons. Proc. Natl. Acad. Sci. U.S.A., 93: 9937-9941, 1996.
47. Zhang, J., Dawson, V.L., Dawson, T.M., and Snyder, S.H., Nitric oxide activation of poly(ADP-ribose) synthetase in neurotoxicity. Science, 263: 687-689, 1994.
48. Berger, N.A., Poly(ADP-ribose) in the cellular response to DNA damage. Radiat. Res., 101: 4-15, 1985.
49. Cosi, C., Suzuki, H., Milani, D., Facci, L., Menegazzi, M., Vantini, G., Kanai, Y., and Skaper, S.D., Poly(ADP-ribose) polymerase: early involvement in glutamateinduced neurotoxicity in cultured cerebellar granule cells. J. Neurosci. Res., 39: 38-46, 1994.
50. Milam, K.M. and Cleaver, J.E., Inhibitors of poly(adenosine diphosphate-ribose) synthesis: effect on other metabolic processes. Science, 223: 589-591, 1984.
51. Pellat-Deceunynck, C., Wietzerbin, J., and Drapier, J.C., Nicotinamide inhibits nitric oxide synthase mRNA induction in activated macrophages. Biochem. J., 297: 53-58, 1994.
52. Takahashi, K., Greenberg, J.H., Jackson, P., Maclin, K., and Zhang, J., Neuroprotective effects of inhibiting poly(ADP-ribose) synthetase on focal cerebral ischemia in rats. J. Cereb. Blood Flow Metab., 17: 1137-1142, 1997.
53. Wang, Z.Q., Auer, B., Stingl, L., Berghammer, H., Haidacher, D., Schweiger, M., and Wagner, E.F., Mice lacking ADPRT and poly(ADP-ribosyl)ation develop normally but are susceptible to skin disease. Genes Dev., 9: 509-520, 1995.
54. de Murcia, J.M., Niedergang, C., Trucco, C., Ricoul, M., Dutrillaux, B., Mark, M., Oliver, F.J., Masson, M., Dierich, A., LeMeur, M., Walztinger, C., Chambon, P., and de Murcia, G., Requirement of poly(ADP-ribose) polymerase in recovery from DNA damage in mice and in cells. Proc. Natl. Acad. Sci. U.S.A., 94: 7303-7307, 1997.
55. Masutani, M., Suzuki, H., Kamada, N., Watanabe, M., Ueda, O., Nozaki, T., Jishage, K., Watanabe, T., Sugimoto, T., Nakagama, H., Ochiya, T., and Sugimura, T., Poly(ADP-ribose) polymerase gene disruption conferred mice resistant to streptozotocin-induced diabetes. Proc. Natl. Acad. Sci. U.S.A., 96: 2301-2304, 1999.
56. Shieh, W.M., Ame, J.C., Wilson, M.V., Wang, Z.Q., Koh, D.W., Jacobson, M.K., and Jacobson, E.L., Poly(ADP-ribose) polymerase null mouse cells synthesize ADPribose polymers. J. Biol. Chem., 273: 30069-30072, 1998.
57. Babiychuk, E., Cottrill, P.B., Storozhenko, S., Fuangthong, M., Chen, Y., O’Farrell, M.K., Van Montagu, M., Inze, D., and Kushnir, S., Higher plants possess two structurally different poly(ADP-ribose) polymerases. Plant J., 15: 635-645, 1998.
58. Berghammer, H., Ebner, M., Marksteiner, R., and Auer, B., pADPRT-2: a novel mammalian polymerizing(ADP-ribosyl)transferase gene related to truncated pADPRT homologues in plants and Caenorhabditis elegans. FEBS Lett., 449: 259-263, 1999.
59. Johansson, M., A human poly(ADP-ribose) polymerase gene family (ADPRTL): cDNA cloning of two novel poly(ADP-ribose) polymerase homologues. Genomics, 57: 442-445, 1999.
60. Ame, J.C., Rolli, V., Schreiber, V., Niedergang, C., Apiou, F., Decker, P., Muller, S., Hoger, T., Menissier-de Murcia, J., and de Murcia, G., PARP-2, a novel mammalian DNA damage-dependent poly(ADP-ribose) polymerase. J. Biol. Chem., 274: 17860-17868, 1999.
61. Eliasson, M.J., Sampei, K., Mandir, A.S., Hurn, P.D., Traystman, R.J., Bao, J., Pieper, A., Wang, Z.Q., Dawson, T.M., Snyder, S.H., and Dawson, V.L., Poly(ADP-ribose) polymerase gene disruption renders mice resistant to cerebral ischemia. Nat. Med., 3: 1089-1095, 1997.
62. Endres, M., Wang, Z.Q., Namura, S., Waeber, C., and Moskowitz, M.A., Ischemic brain injury is mediated by the activation of poly(ADP-ribose)polymerase. J. Cereb. Blood Flow Metab., 17: 1143-1151, 1997.
63. Choi, D.W., At the scene of ischemic brain injury: is PARP a perp? Nat. Med., 3: 1073-1074, 1997.
64. Zhang, J., Li, J.-H., and Lautar, S., Post-ischemia protection by a potent PARP inhibitor in transient cerebral focal ischemia. Soc. Neurosci. Abstr., 24: 1226, 1998.
65. Takahashi, K., Pieper, A.A., Croul, S.E., Zhang, J., Snyder, S.H., and Greenberg, J.H., Post-treatment with an inhibitor of poly(ADP-ribose) polymerase attenuates cerebral damage in focal ischemia. Brain Res., 829: 46-54, 1999.
66. Lautar, S., Pieper, A.A., Verma, A., Snyder, S.H., Li, J.-H., and Zhang, J., Postischemia treatment with GPI 6150 diminishes poly(ADP-ribose) accumulation during ischemia-reperfusion injury in rat brain. Soc. Neurosci. Abstr., 24: 1226, 1998.
67. Mandir, A.S., Przedborski, S., Jackson-Lewis, V., Wang, Z.Q., Simbulan-Rosenthal, C.M., Smulson, M.E., Hoffman, B.E., Guastella, D.B., Dawson, V.L., and Dawson, T.M., Poly(ADP-ribose) polymerase activation mediates 1-methyl-4-phenyl-1, 2,3,6-tetrahydropyridine (MPTP)-induced parkinsonism. Proc. Natl. Acad. Sci. U.S.A., 96: 5774-5779, 1999.
68. Zhang, J., Pieper, A., and Snyder, S.H., Poly(ADP-ribose) synthetase activation: an early indicator of neurotoxic DNA damage. J. Neurochem., 65: 1411-1414, 1995.
69. Cosi, C. and Marien, M., Decreases in mouse brain NAD+ and ATP induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): prevention by the poly(ADPribose) polymerase inhibitor, benzamide. Brain Res., 809: 58-67, 1998.
70. LaPlaca, M.C., Raghupathi, R., Verma, A., Pieper, A.A., Saatman, K.E., Snyder, S.H., and McIntosh, T.K., Temporal patterns of poly(ADP-ribose) polymerase activation in the cortex following experimental brain injury in the rat. J. Neurochem., 73: 205-213, 1999.
71. LaPlaca, M.C., Zhang, J., Li, J.-H., Raghupathi, R., Smith, F., Bareye, F.M., Graham, D.I., and McIntosh, T.K., Pharmacologic inhibition of poly(ADP-ribose) polymerase is neuroprotective following traumatic brain injury in rats, J. Neurotrauma, 16: 976, 1999 (abstract).
72. Whalen, M.J., Clark, R.S., Dixon, C.E., Robichaud, P., Marion, D.W., Vagni, V., Graham, S.H., Virag, L., Hasko, G., Stachlewitz, R., Szabó, C., and Kochanek, P.M., Reduction of cognitive and motor deficits after traumatic brain injury in mice deficient in poly(ADP-ribose) polymerase. J. Cereb. Blood Flow Metab., 19: 835-842, 1999.
73. Love, S., Barber, R., and Wilcock, G.K., Neuronal accumulation of poly(ADP-ribose) after brain ischaemia. Neuropathol. Appl. Neurobiol., 25: 98-103, 1999.
74. Love, S., Barber, R., and Wilcock, G.K., Increased poly(ADP-ribosyl)ation of nuclear proteins in Alzheimer’s disease. Brain, 122: 247-253, 1999.
75. Thiemermann, C., Bowes, J., Myint, F.P., and Vane, J.R., Inhibition of the activity of poly(ADP ribose) synthetase reduces ischemia-reperfusion injury in the heart and skeletal muscle. Proc. Natl. Acad. Sci. U.S.A., 94: 679-683, 1997.
76. Zingarelli, B., Salzman, A.L., and Szabo, C., Genetic disruption of poly(ADP-ribose) synthetase inhibits the expression of P-selectin and intercellular adhesion molecule-1 in myocardial ischemia/reperfusion injury. Circ. Res., 83: 85-94, 1998.
77. Pieper, A.A., Brat, D.J., Krug, D.K., Watkins, C.C., Gupta, A., Blackshaw, S., Verma, A., Wang, Z.Q., and Snyder, S.H., Poly(ADP-ribose) polymerase-deficient mice are protected from streptozotocin-induced diabetes. Proc. Natl. Acad. Sci. U.S.A., 96: 3059-3064, 1999.
78. Burkart, V., Wang, Z.Q., Radons, J., Heller, B., Herceg, Z., Stingl, L., Wagner, E.F., and Kolb, H., Mice lacking the poly(ADP-ribose) polymerase gene are resistant to pancreatic beta-cell destruction and diabetes development induced by streptozocin. Nat. Med., 5: 314-319, 1999.
79. Masiello, P., Cubeddu, T.L., Frosina, G., and Bergamini, E., Protective effect of 3-aminobenzamide, an inhibitor of poly (ADP-ribose) synthetase, against streptozotocin-induced diabetes. Diabetologia, 28: 683-686, 1985.